Danny Villeneuve

Danny Villeneuve serves as the Chief Commercial Officer at Aardvark Therapeutics since May 2025. Previously, Danny held the role of Chief Commercial Officer and Executive Vice President at Ironshore Pharmaceuticals Inc. from January 2020 to December 2024, where responsibilities included leading commercial strategy and execution, resulting in significant revenue growth. Prior experience as an Independent Biopharmaceutical and Biotechnology Consultant from January 2018 to December 2020 involved supporting life sciences through marketing strategy development and business development. Danny also led global marketing at Orexigen Therapeutics from January 2015 to December 2018, focusing on the company’s first product launch outside the U.S. At Shire, contributions spanned from January 2010 to December 2015 in various senior director roles, including overseeing marketing for the Neuroscience business unit and leading the ADHD business unit in Canada. Danny earned a degree from Université du Québec à Trois-Rivières between January 1991 and January 1994.